Erlotinib Hydrochloride | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Erlotinib Hydrochloride
Europe

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

pharmacompass-1-m-2026-01-12

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

pharmacompass-2-m-2025-11-03

Erlotinib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 28 USDMF, 2 CEP/COS, 1 JDMF, 15 EU WC, 15 KDMF, 14 NDC API, 29 Listed Suppliers, $ API Reference Price

67 API Suppliers
28 USDMF
2 CEP/COS
1 JDMF
15 EU WC
15 KDMF
14 NDC API
29 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers, 41 FDA Orange Book, 25 Europe, 10 Canada, 11 South Africa, 6 Listed Dossiers

93 FDF Dossiers
41 FDA Orange Book
25 Europe
10 Canada
11 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Granulation, 15 Controlled & Modified Release, 14 Direct Compression, 14 Disintegrants & Superdisintegrants, 12 Thickeners and Stabilizers, 12 Lubricants & Glidants, 8 Co-Processed Excipients, 6 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 4 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Coloring Agents, 3 API Stability Enhancers, 2 Emulsifying Agents, 1 Solubilizers, 1 Topical, 1 Parenteral, 1 Surfactant & Foaming Agents

41 Coating Systems & Additives
30 Fillers, Diluents & Binders
17 Granulation
15 Controlled & Modified Release
14 Direct Compression
14 Disintegrants & Superdisintegrants
12 Thickeners and Stabilizers
12 Lubricants & Glidants
8 Co-Processed Excipients
6 Film Formers & Plasticizers
6 Taste Masking
5 Empty Capsules
4 Rheology Modifiers
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 Coloring Agents
3 API Stability Enhancers
2 Emulsifying Agents
1 Solubilizers
1 Topical
1 Parenteral
1 Surfactant & Foaming Agents

DIGITAL CONTENT

12 News #PharmaBuzz

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 3 Regulatory FDF Prices

6 US Medicaid Prescriptions
3 Regulatory FDF Prices

MARKET PLACE

3 APIs, 1 FDF Dossiers

3 APIs
1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 3,224 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

25 All

01 3CHEPLAPHARM Registration GmbH

02 3Cipla Europe

03 1Krka Dd, Novo Mesto

04 3Sandoz Pharmaceuticals Sa

05 3Sun Pharmaceutical Industries (Europe) Bv

06 3Tarbis Farma Sl

07 3Teva Bv

08 3Teva Pharma Slu

09 3Tillomed Spain Laboratories Sl

filter Active Ingredients Reset all filters

25 All

01 21Erlotinib Hydrochloride

02 1Erlotinib hydrochloride

03 3Erlotinibhydroklorid

filter Dosage Form Reset all filters

25 All

01 25Film Coated Tablet

filter Country Reset all filters

25 All

01 1Moldova

02 3Norway

03 21Spain

filter Brand Name Reset all filters

25 All

01 3Erlotinib Cipla

02 1Erlotinib Krka

03 3Erlotinib Sandoz

04 3Erlotinib Sun

05 3Erlotinib Tarbis

06 3Erlotinib Teva

07 3Erlotinib Teva Group

08 3Erlotinib Tillomed

09 3Tarceva

List of Suppliers

Product Main Page

01

Cipla Europe

VMX

Not Confirmed

Cipla Europe

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Cipla

Dosage Form : Film Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date : 2020-01-09

Application Number : 84687

Regulatory Info : Cancelled

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Sandoz Pharmaceuticals Sa

VMX

Not Confirmed

Sandoz Pharmaceuticals Sa

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Sandoz

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2018-07-24

Application Number : 83324

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Teva Pharma Slu

VMX

Not Confirmed

Teva Pharma Slu

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2018-09-19

Application Number : 83420

Regulatory Info : Cancelled

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Teva Pharma Slu

VMX

Not Confirmed

Teva Pharma Slu

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Cancelled

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Teva

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 2018-09-19

Application Number : 83421

Regulatory Info : Cancelled

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Teva Bv

VMX

Not Confirmed

Teva Bv

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Teva Group

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2018-07-24

Application Number : 83083

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Tillomed Spain Laboratories Sl

VMX

Not Confirmed

Tillomed Spain Laboratories Sl

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Suspensed

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Tillomed

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2022-04-05

Application Number : 85932

Regulatory Info : Suspensed

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Tillomed Spain Laboratories Sl

VMX

Not Confirmed

Tillomed Spain Laboratories Sl

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Suspensed

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Tillomed

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 2022-04-05

Application Number : 85933

Regulatory Info : Suspensed

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Tillomed Spain Laboratories Sl

VMX

Not Confirmed

Tillomed Spain Laboratories Sl

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Suspensed

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Tillomed

Dosage Form : Film Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-04-05

Application Number : 85934

Regulatory Info : Suspensed

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Tarbis Farma Sl

Country

VMX

Not Confirmed

Tarbis Farma Sl

Country

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Tarbis

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date : 2018-09-21

Application Number : 83432

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Tarbis Farma Sl

Country

VMX

Not Confirmed

Tarbis Farma Sl

Country

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Erlotinib Hydrochloride

Brand Name : Erlotinib Tarbis

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2018-09-21

Application Number : 83431

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.